Yamashita, M., Dellorusso, P. V., Olson, O. C. & Passegué, E. Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis. Nat. Rev. Cancer 20, 365–382 (2020).
Short, N. J. et al. Advances in the treatment of acute myeloid leukemia: new drugs and new challenges. Cancer Discov. 10, 506–525 (2020).
National Cancer Institute Surveillance, Epidemiology and End Results Program. Cancer Stat Facts: Leukemia—Acute Myeloid Leukemia (AML) (National Cancer Institute); https://seer.cancer.gov/statfacts/html/amyl.html
Cai, D., Liu, Z. & Lippincott-Schwartz, J. Biomolecular condensates and their links to cancer progression. Trends Biochem. Sci. 46, 535–549 (2021).
Boija, A., Klein, I. A. & Young, R. A. Biomolecular condensates and cancer. Cancer Cell 39, 174–192 (2021).
Pappu, R. V., Cohen, S. R., Dar, F., Farag, M. & Kar, M. Phase transitions of associative biomacromolecules. Chem. Rev. 123, 8945–8987 (2023).
Alberti, S. & Hyman, A. A. Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing. Nat. Rev. Mol. Cell Biol. 22, 196–213 (2021).
Alberti, S., Gladfelter, A. & Mittag, T. Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates. Cell 176, 419–434 (2019).
Ahn, J. H. et al. Phase separation drives aberrant chromatin looping and cancer development. Nature 595, 591–595 (2021).
Cheng, Y. et al. N6-methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation. Cancer Cell 39, 958–972 (2021).
Chandra, B. et al. Phase separation mediates NUP98 fusion oncoprotein leukemic transformation. Cancer Discov. 12, 1152–1169 (2022).
Smith, T. et al. Organic phase separation opens up new opportunities to interrogate the RNA-binding proteome. Curr. Opin. Chem. Biol. 54, 70–75 (2020).
Wiedner, H. J. & Giudice, J. It’s not just a phase: function and characteristics of RNA-binding proteins in phase separation. Nat. Struct. Mol. Biol. 28, 465–473 (2021).
Feric, M. et al. Coexisting liquid phases underlie nucleolar subcompartments. Cell 165, 1686–1697 (2016).
Frottin, F. et al. The nucleolus functions as a phase-separated protein quality control compartment. Science 365, 342–347 (2019).
Aspesi, A. & Ellis, S. R. Rare ribosomopathies: insights into mechanisms of cancer. Nat. Rev. Cancer 19, 228–238 (2019).
Carotenuto, P., Pecoraro, A., Palma, G., Russo, G. & Russo, A. Therapeutic approaches targeting nucleolus in cancer. Cells 8, 1090 (2019).
Marcel, V. et al. p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell 24, 318–330 (2013).
Erales, J. et al. Evidence for rRNA 2′-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes. Proc. Natl Acad. Sci. USA 114, 12934–12939 (2017).
Yi, Y. et al. A PRC2-independent function for EZH2 in regulating rRNA 2′-O-methylation and IRES-dependent translation. Nat. Cell Biol. 23, 341–354 (2021).
Zhou, F. et al. A dynamic rRNA ribomethylome drives stemness in acute myeloid leukemia. Cancer Discov. 13, 332–347 (2023).
Tessarz, P. et al. Glutamine methylation in histone H2A is an RNA-polymerase-I-dedicated modification. Nature 505, 564–568 (2014).
Iyer-Bierhoff, A. et al. SIRT7-dependent deacetylation of fibrillarin controls histone H2A methylation and rRNA synthesis during the cell cycle. Cell Rep. 25, 2946–2954 (2018).
Yao, R.-W. et al. Nascent pre-rRNA sorting via phase separation drives the assembly of dense fibrillar components in the human nucleolus. Mol. Cell 76, 767–783 (2019).
Platt, R. J. et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159, 440–455 (2014).
Hentze, M. W., Castello, A., Schwarzl, T. & Preiss, T. A brave new world of RNA-binding proteins. Nat. Rev. Mol. Cell Biol. 19, 327–341 (2018).
Elcheva, I. A. & Spiegelman, V. S. Targeting RNA-binding proteins in acute and chronic leukemia. Leukemia 35, 360–376 (2021).
Jayavelu, A. K. et al. The proteogenomic subtypes of acute myeloid leukemia. Cancer Cell 40, 301–317 (2022).
Döhner, H. et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129, 424–447 (2017).
Rodriguez-Corona, U., Sobol, M., Rodriguez-Zapata, L. C., Hozak, P. & Castano, E. Fibrillarin from Archaea to human. Biol. Cell 107, 159–174 (2015).
Shubina, M. Y., Musinova, Y. R. & Sheval, E. V. Nucleolar methyltransferase fibrillarin: evolution of structure and functions. Biochemistry (Mosc.) 81, 941–950 (2016).
Aittaleb, M., Visone, T., Fenley, M. O. & Li, H. Structural and thermodynamic evidence for a stabilizing role of Nop5p in S-adenosyl-L-methionine binding to fibrillarin. J. Biol. Chem. 279, 41822–41829 (2004).
Deffrasnes, C. et al. Genome-wide siRNA screening at biosafety level 4 reveals a crucial role for fibrillarin in Henipavirus infection. PLoS Pathog. 12, e1005478 (2016).
Bremer, A. et al. Deciphering how naturally occurring sequence features impact the phase behaviours of disordered prion-like domains. Nat. Chem. 14, 196–207 (2022).
Ruff, K. M., Dar, F. & Pappu, R. V. Polyphasic linkage and the impact of ligand binding on the regulation of biomolecular condensates. Biophys. Rev. 2, 021302 (2021).
Lafontaine, D. L. J., Riback, J. A., Bascetin, R. & Brangwynne, C. P. The nucleolus as a multiphase liquid condensate. Nat. Rev. Mol. Cell Biol. 22, 165–182 (2021).
Correll, C. C., Bartek, J. & Dundr, M. The nucleolus: a multiphase condensate balancing ribosome synthesis and translational capacity in health, aging and ribosomopathies. Cells 8, 869 (2019).
Elhamamsy, A. R., Metge, B. J., Alsheikh, H. A., Shevde, L. A. & Samant, R. S. Ribosome biogenesis: a central player in cancer metastasis and therapeutic resistance. Cancer Res. 82, 2344–2353 (2022).
Shan, L. et al. Nucleolar URB1 ensures 3′ ETS rRNA removal to prevent exosome surveillance. Nature 615, 526–534 (2023).
Ayadi, L., Motorin, Y. & Marchand, V. Quantification of 2′-O-Me residues in RNA using next-generation sequencing (Illumina RiboMethSeq protocol). Methods Mol. Biol. 1649, 29–48 (2018).
Dong, Z.-W. et al. RTL-P: a sensitive approach for detecting sites of 2′-O-methylation in RNA molecules. Nucleic Acids Res. 40, e157 (2012).
Tafforeau, L. et al. The complexity of human ribosome biogenesis revealed by systematic nucleolar screening of pre-rRNA processing factors. Mol. Cell 51, 539–551 (2013).
Liao, H. et al. Human NOP2/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C/D snoRNPs. Nucleic Acids Res. 50, 10695–10716 (2022).
Zhou, F. et al. AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia. Nat. Cell Biol. 19, 844–855 (2017).
Pauli, C. et al. Site-specific methylation of 18S ribosomal RNA by SNORD42A is required for acute myeloid leukemia cell proliferation. Blood 135, 2059–2070 (2020).
Ugolini, I. et al. Chromatin localization of nucleophosmin organizes ribosome biogenesis. Mol. Cell 82, 4443–4457 (2022).
Schmidt, E. K., Clavarino, G., Ceppi, M. & Pierre, P. SUnSET, a nonradioactive method to monitor protein synthesis. Nat. Methods 6, 275–277 (2009).
Venugopal, S., Bar-Natan, M. & Mascarenhas, J. O. JAKs to STATs: a tantalizing therapeutic target in acute myeloid leukemia. Blood Rev. 40, 100634 (2020).
Hu, X., Li, J., Fu, M., Zhao, X. & Wang, W. The JAK/STAT signaling pathway: from bench to clinic. Signal Transduct. Target Ther. 6, 402 (2021).
Zhang, L. et al. Myc-Miz1 signaling promotes self-renewal of leukemia stem cells by repressing Cebpα and Cebpδ. Blood 135, 1133–1145 (2020).
Schaub, F. X. et al. Pan-cancer alterations of the MYC oncogene and its proximal network across the Cancer Genome Atlas. Cell Syst 6, 282–300 (2018).
Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417–425 (2015).
Burger, K. et al. Chemotherapeutic drugs inhibit ribosome biogenesis at various levels. J. Biol. Chem. 285, 12416–12425 (2010).
Jin, J. et al. Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial. Lancet Oncol. 14, 599–608 (2013).
Mi, R. et al. Efficacy and safety of homoharringtonine for the treatment of acute myeloid leukemia: a meta-analysis. Clin. Lymphoma Myeloma Leuk. 21, e752–e767 (2021).
Chen, X.-J. et al. Homoharringtonine deregulates MYC transcriptional expression by directly binding NF-κB repressing factor. Proc. Natl Acad. Sci. USA 116, 2220–2225 (2019).
Ruff, K. M., Dar, F. & Pappu, R. V. Ligand effects on phase separation of multivalent macromolecules. Proc. Natl Acad. Sci. USA 118, e2017184118 (2021).
Leicher, R. et al. Single-stranded nucleic acid binding and coacervation by linker histone H1. Nat. Struct. Mol. Biol. 29, 463–471 (2022).
Mitrea, D. M. et al. Self-interaction of NPM1 modulates multiple mechanisms of liquid–liquid phase separation. Nat. Commun. 9, 842 (2018).
Hein, N., Hannan, K. M., George, A. J., Sanij, E. & Hannan, R. D. The nucleolus: an emerging target for cancer therapy. Trends Mol. Med. 19, 643–654 (2013).
Ide, S., Imai, R., Ochi, H. & Maeshima, K. Transcriptional suppression of ribosomal DNA with phase separation. Sci. Adv. 6, eabb5953 (2020).
Hannan, R. D., Drygin, D. & Pearson, R. B. Targeting RNA polymerase I transcription and the nucleolus for cancer therapy. Expert Opin. Ther. Targets 17, 873–878 (2013).
Bywater, M. J. et al. Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 22, 51–65 (2012).
Hein, N. et al. Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population. Blood 129, 2882–2895 (2017).
Falini, B., Brunetti, L., Sportoletti, P. & Martelli, M. P. NPM1-mutated acute myeloid leukemia: from bench to bedside. Blood 136, 1707–1721 (2020).
Gürel, G., Blaha, G., Moore, P. B. & Steitz, T. A. U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome. J. Mol. Biol. 389, 146–156 (2009).
Chen, B. et al. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155, 1479–1491 (2013).
Raj, A. & Tyagi, S. Detection of individual endogenous RNA transcripts in situ using multiple singly labeled probes. Methods Enzymol. 472, 365–386 (2010).
Riback, J. A. et al. Composition-dependent thermodynamics of intracellular phase separation. Nature 581, 209–214 (2020).
Zhang, X. M. et al. A proline-rich motif on VGLUT1 reduces synaptic vesicle super-pool and spontaneous release frequency. eLife 8, e50401 (2019).
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.nature.com/articles/s41556-024-01420-z